Last Updated on January 25, 2020 by HepFree NYC
NYC Department of Health | Viral Hepatitis
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
-
Hep C In my Own Words Essay Contest
News
Please help spread the word! You can easily add a link to your webpage to help get the word out about this year's essay contest. Click here to find out more. Please consider forwarding this email to your contacts and listservs.
-
Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment
News
Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $1...
-
Symposium | Viral Hepatitis Research Symposium: Equity in Prevention & Treatment
News, HepCX News
A successful Viral Hepatitis Research Symposium took place on May 24, 2018 at Rockefeller University. This event brought together more than 200 local medical providers, laboratory directors, community service providers, policy-makers and other stakeholders, and DOHMH staff to r...
-
Press Release | Hep B & Hep C: Annual Report of Activities, 2015 (NYC Health Dept)
News, Reports, HepCX News
Health Department Releases Report On Hepatitis Surveillance And Programs In New York City, Launches Ad Campaign To Promote New Health Care Services For People Living With Viral Hepatitis
-
World Hepatitis Day – NYC 2016
News
On World Hepatitis Day 2016, hundreds of New Yorkers participated in educational forums, social media campaigns and free hepatitis screenings.
-
FDA Approves Epclusa – 1st Pan-Genotypic Hep C Med
News, Hepatitis C, HepCX News, Pharmaceutical
The FDA has approved the drug Epclusa to treat adult patients with chronic Hep C both with and without cirrhosis.
-
NYS Mediciad Hep C Approved Prescriber List
News, CME, CMS, Medicaid
On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
-
Seeking Nominations for NYC Hep B Coalition Community Chair!
News
The NYC Hep B Coalition is currently accepting nominations for a new Community Chair. See responsibilities and qualifications, nominate yourself or someone else!








